Meeting 10-Year DSCSA Serialization Mandate Requires Industry Big Push In Final Year
Executive Summary
HDA finds much progress to report in seventh annual Serialization Readiness Survey, but quite a lot of work remains for many drug manufacturers and distributors if they are to meet November 2023 compliance deadline.
You may also be interested in...
As Supply Chain Partners Ramp Up For November DSCSA Deadline, US FDA Gives Them Another Year
Potential distribution hitches could spark shortages of legitimate drugs if the system is not fully ready for package-level tracing requirements, US FDA says in delaying enforcement of the program a decade in the making. Poll shows supply chain partners were making significant progress in preparing for the 27 November deadline.
AAM Calls For Congress And FDA To End Shortages By Easing Up On Generics Quality, Pricing
Remote inspection alternatives could allow quicker resolution of quality issues that are holding up US imports, says association for generic drug manufacturers. AAM adds that adjusting a Medicaid inflation penalty could relieve unfair price pressures.
AAM Calls For Congress And FDA To End Shortages By Easing Up On Generics Quality, Pricing
Remote inspection alternatives could allow quicker resolution of quality issues that are holding up US imports, says association for generic drug manufacturers. AAM adds that adjusting a Medicaid inflation penalty could relieve unfair price pressures.